| Tue, Feb 9, 2010 |
| |
FACET BIOTECH CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online (Tue 8:16am)
|
| Mon, Feb 8, 2010 |
| |
Cash Rich, No Debt Stocks at Investopedia (Mon, Feb 8)
|
| Sat, Feb 6, 2010 |
| |
[$$] 13D Filings at Barrons.com (Sat, Feb 6)
|
| Fri, Feb 5, 2010 |
| |
President Sergey Brin Sells $44.3M Worth of Google TheStreet.com (Fri, Feb 5)
|
| Wed, Feb 3, 2010 |
| |
FACET BIOTECH CORP Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online (Wed, Feb 3)
|
| Tue, Feb 2, 2010 |
| |
Facet Biotech to Present at 12th Annual Bio CEO & Investor Conference Marketwire (Tue, Feb 2)
|
| Mon, Feb 1, 2010 |
| |
President James Truchard Sells $7.7M National Instruments TheStreet.com (Mon, Feb 1)
|
| Tue, Jan 26, 2010 |
| |
FACET BIOTECH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online (Tue, Jan 26)
|
| Wed, Jan 20, 2010 |
| |
Those Are Fighting Words at Motley Fool (Wed, Jan 20)
|
| Mon, Jan 11, 2010 |
| |
Facet Biotech receiving $15 million from partner AP (Mon, Jan 11)
|
| |
Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors CNW Group (Mon, Jan 11)
|
| |
FACET BIOTECH CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online (Mon, Jan 11)
|
| |
Jennerex Appoints Dr. Hoyoung Huh to Its Board of Directors PRNewswire (Mon, Jan 11)
|
| |
Facet Biotech Announces Enrollment of First Patient in Phase 2 Study of Elotuzumab in Patients With Relapsed Multiple Myeloma Marketwire (Mon, Jan 11)
|
| Mon, Dec 21, 2009 |
| |
Facet Rebuffs Biogen: Will a White Knight Emerge? at Seeking Alpha (Mon, Dec 21)
|
| Sun, Dec 20, 2009 |
| |
Facet Board Pleased with Rejection of Biogen Bid at Seeking Alpha (Sun, Dec 20)
|
| Fri, Dec 18, 2009 |
| |
CelgeneÂs Surprising New Hope for Blood Cancer at Minyanville.com (Fri, Dec 18)
|
| Thu, Dec 17, 2009 |
| |
Merck and J&J Land Deals; Biogen Idec, Not So Much at The Wall Street Journal Online (Thu, Dec 17)
|
| |
Facet shareholders reject Biogen takeover bid AP (Thu, Dec 17)
|
| |
Facet shareholders reject Biogen's tender offer at MarketWatch (Thu, Dec 17)
|
| Older Headlines |
|
|
|
|